The clinical efficacy of auricular acupuncture in the treatment of frequent episodic tension-type headache: a single-blind randomized controlled trial
- PMID: 40842010
- PMCID: PMC12369207
- DOI: 10.1186/s12906-025-05063-x
The clinical efficacy of auricular acupuncture in the treatment of frequent episodic tension-type headache: a single-blind randomized controlled trial
Abstract
Background: Frequent episodic tension-type headache (FETTH) is a significant public-health concern. Scientific research has demonstrated that acupuncture can improve the clinical symptoms of FETTH.
Purpose: This study aimed to compare the efficacy and safety of auricular acupuncture and sham acupuncture in treating FETTH.
Methods: This was a randomized controlled trial. Participants with FETTH were randomly assigned in a 1:1 ratio to receive auricular acupuncture or sham acupuncture for 4 weeks, with follow-up lasting for up to 24 weeks. The primary outcomes were measured using the headache index and visual analog scale (VAS) score. Secondary outcomes included the Hamilton Anxiety Scale (HAMA) score, Hamilton Depression Scale (HAMD) score, blood flow velocity in the anterior cerebral artery (ACA), middle cerebral artery (MCA), and posterior cerebral artery (PCA) (VACA, VMCA, and VPCA, respectively), and the usage of acute headache medications. Adverse events were also recorded to assess safety.
Results: Compared with the sham acupuncture group, the auricular acupuncture group showed significant improvements in VAS score (2 (1.25, 2) vs. 3 (2, 3.5) at 24 h, P < 0.001; 2 (1.25, 2) vs. 2 (2, 3) at the 2nd week, P = 0.004; 2 (1, 2) vs. 2 (1.5, 3) at the 4th week, P = 0.015), headache index (4 (2, 7) vs. 7 (4, 9) at the 4th week, P = 0.016), HAMA score (11.69 ± 2.70) vs. (14.24 ± 3.20) at the 4th week, P < 0.001; (9.83 ± 2.71) vs. (11.95 ± 2.59) at the 8th week, P = 0.001; (9.67 ± 2.65) vs. (11.76 ± 3.00) at the 24th week, P = 0.002), HAMD score ((14.25 ± 2.68) vs. (15.89 ± 3.48) at the 4th week, P = 0.027,) VACA (85.5 (85, 86) vs. 83 (83, 84) at the 4th week, P < 0.001), VPCA (82 (81, 83) vs. 78 (77, 79) at the 4th week, P < 0.001), and usage of acute headache medications (8 (7, 10) vs. 9 (8, 11) at the 4th week, P = 0.030). The incidence of adverse events was similar between the two groups (P = 1.000).
Conclusion: This study found that auricular acupuncture effectively improved the clinical symptoms of FETTH and had relatively fewer side effects.
Trial registration: The study was retrospectively registered in the International Traditional Medicine Clinical Trial Registry (ITMCTR2025000363) on January 20, 2025.
Keywords: Auricular acupoints; Auricular acupuncture; Clinical efficacy; Frequent episodic tension-type headache.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This project has been approved by the Ethics Committee of the Affiliated Hospital of Shaanxi University of Chinese Medicine (Ethics Approval No. SZFYIEC-PJ-2023 No [27]). The study was planned in accordance with the Declaration of Helsinki. Research participants were informed of the study objectives and methods, the confidentiality of their information, potential side effects of the research, and their right to withdraw from the study at any time. All participants provided written informed consent prior to their participation in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures



Similar articles
-
Acupuncture for the prevention of tension-type headache.Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD007587. doi: 10.1002/14651858.CD007587.pub2. Cochrane Database Syst Rev. 2016. PMID: 27092807 Free PMC article.
-
Acupuncture for the prevention of episodic migraine.Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD001218. doi: 10.1002/14651858.CD001218.pub3. Cochrane Database Syst Rev. 2016. PMID: 27351677 Free PMC article.
-
Three-dimensional kinematic analysis can improve the efficacy of acupoint selection for post-stroke patients with upper limb spastic paresis: A randomized controlled trial.J Integr Med. 2025 Jan;23(1):15-24. doi: 10.1016/j.joim.2024.12.004. Epub 2024 Dec 12. J Integr Med. 2025. PMID: 39710552 Clinical Trial.
-
Aspirin for acute treatment of episodic tension-type headache in adults.Cochrane Database Syst Rev. 2017 Jan 13;1(1):CD011888. doi: 10.1002/14651858.CD011888.pub2. Cochrane Database Syst Rev. 2017. PMID: 28084009 Free PMC article.
-
Botulinum toxins for the prevention of migraine in adults.Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD011616. doi: 10.1002/14651858.CD011616.pub2. Cochrane Database Syst Rev. 2018. PMID: 29939406 Free PMC article.
References
-
- Jensen R. Peripheral and central mechanisms in tension-type headache: an update. Cephalalgia. 2003;23(Suppl 1):49–52. 10.1046/j.1468-2982.2003.00574.x. - PubMed
-
- Jensen RH. Tension-Type headache - The normal and most prevalent headache. Headache. 2018;58(2):339–45. 10.1111/head.13067. - PubMed
-
- The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. 10.1177/0333102413485658. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources